Your browser doesn't support javascript.
loading
Iron overload patients with unknown etiology from national survey in Japan.
Ikuta, Katsuya; Hatayama, Mayumi; Addo, Lynda; Toki, Yasumichi; Sasaki, Katsunori; Tatsumi, Yasuaki; Hattori, Ai; Kato, Ayako; Kato, Koichi; Hayashi, Hisao; Suzuki, Takahiro; Kobune, Masayoshi; Tsutsui, Miyuki; Gotoh, Akihiko; Aota, Yasuo; Matsuura, Motoo; Hamada, Yuzuru; Tokuda, Takahiro; Komatsu, Norio; Kohgo, Yutaka.
Affiliation
  • Ikuta K; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka-Higashi, Asahikawa, Hokkaido, 078-8510, Japan. ikuta@asahikawa-med.ac.jp.
  • Hatayama M; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka-Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
  • Addo L; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka-Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
  • Toki Y; Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka-Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
  • Sasaki K; Department of Gastrointestinal Immunology and Regenerative Medicine, Asahikawa Medical University, 2-1-1-1, Midorigaoka-Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
  • Tatsumi Y; Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan.
  • Hattori A; Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan.
  • Kato A; Department of Hospital Pharmacy, Nagoya University, Nagoya, Aichi, Japan.
  • Kato K; Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan.
  • Hayashi H; Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan.
  • Suzuki T; Laboratory of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Aichi, Japan.
  • Kobune M; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Tsutsui M; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
  • Gotoh A; Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
  • Aota Y; Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
  • Matsuura M; Department of Internal Medicine, Kohsei Chuo General Hospital, Tokyo, Japan.
  • Hamada Y; Department of Nephrology, Metabology and Immunology, Sakai City Medical Center, Sakai, Osaka, Japan.
  • Tokuda T; Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Osaka, Japan.
  • Komatsu N; Department of Cardiovascular Medicine, Saiseikai Yokohama City Eastern Hospital, Yokohama, Kanagawa, Japan.
  • Kohgo Y; Division of Hematology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Int J Hematol ; 105(3): 353-360, 2017 Mar.
Article in En | MEDLINE | ID: mdl-27848180
ABSTRACT
Transfusion is believed to be the main cause of iron overload in Japan. A nationwide survey on post-transfusional iron overload subsequently led to the establishment of guidelines for iron chelation therapy in this country. To date, however, detailed clinical information on the entire iron overload population in Japan has not been fully investigated. In the present study, we obtained and studied detailed clinical information on the iron overload patient population in Japan. Of 1109 iron overload cases, 93.1% were considered to have occurred post-transfusion. There were, however, 76 cases of iron overload of unknown origin, which suggest that many clinicians in Japan may encounter some difficulty in correctly diagnosing and treating iron overload. Further clinical data were obtained for 32 cases of iron overload of unknown origin; median of serum ferritin was 1860.5 ng/mL. As occurs in post-transfusional iron overload, liver dysfunction was found to be as high as 95.7% when serum ferritin levels exceeded 1000 ng/mL in these patients. Gene mutation analysis of the iron metabolism-related genes in 27 cases of iron overload with unknown etiology revealed mutations in the gene coding hemojuvelin, transferrin receptor 2, and ferroportin; this indicates that although rare, hereditary hemochromatosis does occur in Japan.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Iron Overload Type of study: Diagnostic_studies / Etiology_studies / Guideline / Qualitative_research Country/Region as subject: Asia Language: En Journal: Int J Hematol Year: 2017 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Iron Overload Type of study: Diagnostic_studies / Etiology_studies / Guideline / Qualitative_research Country/Region as subject: Asia Language: En Journal: Int J Hematol Year: 2017 Type: Article Affiliation country: Japan